This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Shigeyama, Y.
Right arrow Articles by Noda, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Shigeyama, Y.
Right arrow Articles by Noda, T.

 Previous Article  |  Next Article 

Molecular and Cellular Biology, May 2008, p. 2971-2979, Vol. 28, No. 9
0270-7306/08/$08.00+0     doi:10.1128/MCB.01695-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Biphasic Response of Pancreatic β-Cell Mass to Ablation of Tuberous Sclerosis Complex 2 in Mice{triangledown}

Yutaka Shigeyama,1 Toshiyuki Kobayashi,2,{dagger} Yoshiaki Kido,1* Naoko Hashimoto,1 Shun-ichiro Asahara,1 Tomokazu Matsuda,1 Akihiko Takeda,1 Tae Inoue,1 Yuki Shibutani,1 Maki Koyanagi,1 Tohru Uchida,1 Maki Inoue,3 Okio Hino,2,{dagger} Masato Kasuga,1 and Tetsuo Noda3

Department of Internal Medicine, Division of Diabetes, Metabolism, and Endocrinology, Kobe University Graduate School of Medicine, Kobe 650-0017, Japan,1 Department of Experimental Pathology,2 Department of Cell Biology, Cancer Institute, Japanese Foundation of Cancer Research, Tokyo 135-8550, Japan3

Received 14 September 2007/ Returned for modification 17 October 2007/ Accepted 15 February 2008

Recent studies have demonstrated the importance of insulin or insulin-like growth factor 1 (IGF-1) for regulation of pancreatic β-cell mass. Given the role of tuberous sclerosis complex 2 (TSC2) as an upstream molecule of mTOR (mammalian target of rapamycin), we examined the effect of TSC2 deficiency on β-cell function. Here, we show that mice deficient in TSC2, specifically in pancreatic β cells (βTSC2–/– mice), manifest increased IGF-1-dependent phosphorylation of p70 S6 kinase and 4E-BP1 in islets as well as an initial increased islet mass attributable in large part to increases in the sizes of individual β cells. These mice also exhibit hypoglycemia and hyperinsulinemia at young ages (4 to 28 weeks). After 40 weeks of age, however, the βTSC2–/– mice develop progressive hyperglycemia and hypoinsulinemia accompanied by a reduction in islet mass due predominantly to a decrease in the number of β cells. These results thus indicate that TSC2 regulates pancreatic β-cell mass in a biphasic manner.

* Corresponding author. Mailing address: Department of Internal Medicine, Division of Diabetes, Metabolism, and Endocrinology, Kobe University Graduate School of Medicine, 7-5-1 Kusunoki-cho, Chuo-ku, Kobe 650-0017, Japan. Phone: 81-78-382-5861. Fax: 81-78-382-2080. E-mail: kido{at}med.kobe-u.ac.jp

{triangledown} Published ahead of print on 3 March 2008.

{dagger} Present address: Department of Molecular Pathogenesis, Juntendo University Graduate School of Medicine, Tokyo 113-8421, Japan.

Molecular and Cellular Biology, May 2008, p. 2971-2979, Vol. 28, No. 9
0270-7306/08/$08.00+0     doi:10.1128/MCB.01695-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Pollizzi, K., Malinowska-Kolodziej, I., Doughty, C., Betz, C., Ma, J., Goto, J., Kwiatkowski, D. J. (2009). A hypomorphic allele of Tsc2 highlights the role of TSC1/TSC2 in signaling to AKT and models mild human TSC2 alleles. Hum Mol Genet 18: 2378-2387 [Abstract] [Full Text]  
  • Hamada, S., Hara, K., Hamada, T., Yasuda, H., Moriyama, H., Nakayama, R., Nagata, M., Yokono, K. (2009). Upregulation of the Mammalian Target of Rapamycin Complex 1 Pathway by Ras Homolog Enriched in Brain in Pancreatic {beta}-Cells Leads to Increased {beta}-Cell Mass and Prevention of Hyperglycemia. Diabetes 58: 1321-1332 [Abstract] [Full Text]  
  • Inoki, K., Guan, K.-L. (2009). Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment. Hum Mol Genet 18: R94-R100 [Abstract] [Full Text]  
  • Balcazar, N., Sathyamurthy, A., Elghazi, L., Gould, A., Weiss, A., Shiojima, I., Walsh, K., Bernal-Mizrachi, E. (2009). mTORC1 Activation Regulates {beta}-Cell Mass and Proliferation by Modulation of Cyclin D2 Synthesis and Stability. J. Biol. Chem. 284: 7832-7842 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»